Roche Holding, CH1499059983

Roche Holding stock pre-market: investor event on November 2

Published on 10/26/2026 at 07:35 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWS
Roche operates across medicines and diagnostics. At Lang & Schwarz the stock trades pre-market at EUR 427.50 on October 26, 2026.

Investor calendar and business

  • The next listed event is Roche’s Berenberg Pharma CFO Series on November 2, 2026.
  • Roche’s 2026 investor materials cover medicines and diagnostics.
  • Roche Holding stock trades pre-market at EUR 427.50 at 7:33 a.m. CET at Lang & Schwarz on October 26, 2026.
Roche Holding AG CH0012032048 – Diagnostik-Analysegerät verarbeitet biologische Proben im modernen klinischen Labor, Illustration mit AI erstellt.

Roche Holding’s investor calendar lists the virtual Berenberg Pharma CFO Series 2026 for November 2, 2026, at 3:00 p.m. CET in Basel, Switzerland, according to the Roche investor relations page. Roche Holding stock trades pre-market at EUR 427.50 at 7:33 a.m. CET at Lang & Schwarz on October 26, 2026.

Next investor event

The Berenberg Pharma CFO Series is the next event listed for Roche investors and is scheduled as a virtual event on November 2, 2026, at 3:00 p.m. CET, with Basel given as the location by Roche’s investor relations calendar.

Before the Xetra open

The quote was recorded at 7:33 a.m. CET, before the Xetra session begins. The further course from the Xetra open at 9:00 a.m. CET is shown by the continuously updated real-time quote of Roche Holding stock.

Medicines and diagnostics

Roche operates across medicines and diagnostics, with its investor materials covering pharmaceutical products and diagnostic tests, as described on the Roche investor relations page. Market context: Market report SMI.

More news and analysis on Roche Holding stock

Disclaimer...
en | CH1499059983 | ROCHE HOLDING | boerse | 70411824 | bgmi